Immunosuppression with Cytembena: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production.
D000179:Acrylates / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D005069:Evaluation Studies as Topic; D005260:Female; D006462:Hemolytic Plaque Technique; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D051379:Mice; D013154:Spleen / Q000166:cytology*
D000179:Acrylates; D000970:Antineoplastic Agents